Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT800 Prophylaxis and On-demand Treatment in Previously Treated Severe Hemophilia A Patients
CTR20191311Phase 4Completed
- Sponsor
- Shenzhou Cell Engineering Co., Ltd.
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Shenzhou Cell Engineering Co., Ltd.. Started Jul 2019; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20191311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191311.